Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Rev Invest Clin ; 66(3): 252-60, 2014.
Article in Spanish | MEDLINE | ID: mdl-25695242

ABSTRACT

INTRODUCTION: During the fluid phase of hemostasis, fibrinogen is converted into fibrin, but other hemostatic factors are required. Reference values of hemostatic factors are established by manufacturers producing reagents using individuals with a specific genetic background. OBJECTIVE: To establish reference values for hemostatic factors in the Mexican indigenous and Mestizo populations. MATERIAL AND METHODS: We carried out a cross-sectional, descriptive study of healthy adult Mexicans. Clotting activity was evaluated using coagulometric assays. Blood donors were informed about the nature of the study and informed consent was obtained prior to blood being drawn. The protocol was approved by the Ethics Committee of our institution. RESULTS: One hundred and twenty samples were assayed (60 females and 60 males). Fibrinogen was higher in mestizos and in females. Reference values for factor XII ranged from 40-170% in indigenous subjects and from 36-159% in mestizos. Factor VIII ranged from 57-160% in indigenous subjects and from 51-209% in mestizo subjects. Reference values for the other hemostatic factors were also clearly different from the commercial reference values. Reference values for hemostatic factors in the Mexican population are different from traditionally used commercial reference values. There were significant differences between indigenous and mestizo Mexicans in the concentration of hemostatic factors with a tendency among mestizos to have higher factor concentrations. Low levels of plasma factor XII are frequent and perhaps may represent a risk factor for thrombotic events. Using these reference values may individualize the reposition of factors in Mexican hemophiliac patients.


Subject(s)
Blood Coagulation Factors/physiology , Blood Coagulation Tests , Hemostasis/physiology , Adult , Blood Donors , Cross-Sectional Studies , Ethnicity , Factor VIII/physiology , Factor XII/physiology , Female , Fibrinogen/physiology , Humans , Male , Mexico , Reference Values
7.
Rev. Fed. Odontol. Colomb ; (201): 37-51, oct. 2001-feb. 2002. tab
Article in Spanish | LILACS | ID: lil-351858

ABSTRACT

La gestación es un proceso complejo, en el que se llevan a cabo cambios importantes en la mujer, tanto a nivel fisiológico como psicológico, en el cual el medio ambiente familiar y el entorno social cumplen roles trascendentales para la salud del binomio madre-hijo. Los eventos biológicos, que van desde cambios en el aspecto físico de la mujer, como son el progresivo aumento de peso y de volumen, alteración en la coloración de la piel y en las mucosas genitales, hiperflexibilidad de las articulaciones, hasta cambios fisiológicos mayores como son los ocurridos en el sistema cardiovascular, urinario, digestivo, respiratorio, de coagulación y órganos reproductivos. Las hormonas sexuales aumentan su producción y la mujer está en desbalance inmunológico, lo que la hace susceptible a agresiones a la salud, respecto de la mujer no grávida. En cuanto a los cambios psicológicos, éstos son más importantes cuanto más condiciones desfavorables rodeen la gestación, el parto y el puerperio. Así, la adolescente se enfrenta con frecuencia al abandono de su pareja, a la expulsión de la casa paterna y la privación de cualquier apoyo de su familia, lo que puede llevarla al aborto, a la prostitución, al abandono, a la soledad triste e inmensa. Si damos un vistazo a los aspectos sociales, nuestra sociedad machista sigue discriminando a la mujer gestante en su trabajo y en su estudio. Las separaciones conyugales son cada vez más frecuentes y la mujer debe enfrentarse sola al mantenimiento económico del hogar y a la protección de sus hijos. En el caso de la mujer puérpera, el reintegrarse a los oficios de la casa la hace vulnerable a sufrir quebrantos en la salud, ya sea física como psicológica. Para romper con todo esto, es necesaria la ayuda de la familia, especialmente de la madre, del personal de salud que debe comprender y respetar la individualidad, las costumbres, y dar calidez con calidad en el cuidado de la mujer. Este cuidado no puede terminar con el parto: se requiere que el personal de salud, especialmente la enfermera, siga vigilando a la mujer, hasta por lo menos dos semanas después. El odontólogo ocupa un espacio bien importante dentro del equipo de salud para el tratamiento del bionomio madre-hijo. Es necesario tomarlo y defenderlo haciendo gala así como de su idoneidad científica, del amor y de la entrega cálida, en procura de madres sanas y de niños felices


Subject(s)
Humans , Adolescent , Female , Pregnancy , Infant, Newborn , Infant , Pregnancy , Comprehensive Dental Care/statistics & numerical data , Bacterial Infections , Breast Feeding , Clinical Diagnosis , Colombia , Dental Caries , Depression, Postpartum/epidemiology , Stress, Psychological/epidemiology , Stress, Psychological/etiology , Blood Coagulation Factors/physiology , Family Relations , Heart Diseases , Hypertension/epidemiology , Maternal-Child Health Centers , Morbidity Surveys , Mother-Child Relations , Mouth Diseases , Natural Childbirth , Maternal Nutrition , Obstetric Labor, Premature , Patient Care Team , Periodontal Diseases , Pregnancy in Adolescence , Pregnancy Outcome , Pregnancy Trimester, First , Prejudice , Socioeconomic Factors , Weight Gain
8.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 11(5): 1013-1022, set.-out. 2001.
Article in Portuguese | LILACS | ID: lil-391569

ABSTRACT

A principal preocupação diante de quadros de hemorragia no pós-operatório de cirurgia cardíaca é a de preveni-los, mais que tratá-los. Durante a cirurgia cardíaca, ocorrem diversas alterações hemostáticas, que se sobrepõem àquelas associadas às diferentes cardiopatias. Além disso, é importante prevenir, tanto em adultos como em crianças, eventos trombóticos, tais como a trombose venosa profunda, a embolia pulmonar e a oclusão de enxerto.


Subject(s)
Humans , Infant, Newborn , Child , Adult , Embolism , Blood Coagulation Factors/physiology , Hemostasis, Surgical/methods , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use , Thrombosis , Aspirin , Extracorporeal Circulation , Heart Valves , Heart Failure , Postoperative Period , Risk Factors , Thoracic Surgery , Ticlopidine
12.
Invest Clin ; 39(3): 213-29, 1998 Sep.
Article in Spanish | MEDLINE | ID: mdl-9780555

ABSTRACT

Vitamin K is a cofactor for the synthesis of blood coagulation Factors II, VII, IX and X, and inhibitors such as Protein C and S and bone matrix protein. Its active form is a coenzyme in the glutamic acid carboxylation. Vitamin K-dependent factors form enzymatic complexes with calcium and membrane phospholipids. The insufficiency of gamma glutamic carboxylation impairs the hemostatic function. Hereditary deficiencies, antibiotics and oral anticoagulants, decrease the capacity of complex formation giving way to hemorrhage or thrombosis, or bone mass disturbances which are easily treated with administration of Vitamin K. The main causes of Vitamin K deficiency are lack of hepatic storage in newborns, liver insufficiency, malabsorption, dietetic deficiency, therapy with the antibiotics and coumarin administration. For the study of Vitamin K there are methods to measure the Vit K dependent proteins and as well methods to measure specifically the quinonas.


Subject(s)
Vitamin K Deficiency , Vitamin K , Adult , Anticoagulants/pharmacology , Blood Coagulation/physiology , Blood Coagulation Factors/physiology , Coumarins/pharmacology , Enzymes/physiology , Humans , Infant, Newborn , Intestinal Absorption , Liver Diseases/metabolism , Models, Biological , Osteocalcin/physiology , Vitamin K/analysis , Vitamin K/antagonists & inhibitors , Vitamin K/pharmacology , Vitamin K/physiology
16.
Rev Invest Clin ; 48(3): 223-9, 1996.
Article in Spanish | MEDLINE | ID: mdl-8966383

ABSTRACT

The proportion of identifiable causes of familial thrombophilia has increased from 5-10% to 60-70% since the identification of activated protein C resistance (aPCR) in February 1993 by Dahlbäck et al. A mutation in the factor V gene (G-->A, 1691) leads to the so called Leiden mutation (R 506 Q) that produces a mutated factor V resistant to the catalytic action of activated protein C (aPC), yet normal in its procoagulant properties. This recently identified aPCR is in Nordic populations the most prevalent and well defined genetic defect associated with disease so far described. Its prevalence in the general population ranges from 0% to up to 15% and suggests that a positive genetic selection pressure has been involved. The aPCR phenotype can be assessed in vitro by measurement of the prolongation of the activated partial thromboplastin time in the presence of aPC, whereas the aPCR genotype is studied using polymerase chain reaction searching for the Arg to Gln mutation in the coagulation factor V gene. Some acquired conditions such as the presence of lupus anticoagulants, antiphospholipid antibodies, pregnancy, liver disease and contraceptives may lead into the aPCR phenotype. The aPCR search must be the initial step in the study of a patient with thrombophilia, either inherited or acquired aPCR together with protein C, protein S and antithrombin III explain 60 to 70% of cases of familial thrombophilia.


Subject(s)
Factor V Deficiency/complications , Protein C/physiology , Thrombosis/genetics , Antithrombin III/analysis , Blood Coagulation Factors/analysis , Blood Coagulation Factors/physiology , DNA Mutational Analysis , Enzyme Activation , Factor V/genetics , Factor V Deficiency/epidemiology , Female , Humans , Male , Mexico/epidemiology , Partial Thromboplastin Time , Phenotype , Pregnancy , Pregnancy Complications, Hematologic/epidemiology , Pregnancy Complications, Hematologic/etiology , Prevalence , Protein S/analysis , Thrombosis/blood
17.
Rev. méd. (La Paz) ; 3(1): 267-70, ene.-mar. 1996. tab
Article in Spanish | LILACS | ID: lil-196506

ABSTRACT

Determinamos la acción de los cambios hormonales, progesterona y estrogeno sobre la hematopoyesis, hemostasia, coagulacion y fibrinolisis, en mujeres nativas de la altura. Se estudio 50 casos, con se respectiva ficha clinica, antes y despues de ciclo menstrual. Se correlacionaron factores geneticos (Grupos, sanguineos: A, B, O). Los sujetos del grupo O y AB, mostraron disminucion significativa de sus reticulocitos (p<0.001). En cambio, los del grupo A y B, aumentaron el numero de estas celulas (p<0.001). Ademas en el grupo sanguineo O, se observo que hacen uso de las reservas de Fe (Protoporfirina), a diferencia de los otros grupos. Referente a la hemostasia, el estudio cuantitativo y cualitativo (numeracion, agragacion y fragilidad capilar), mostraron una disminucion significativa (p<0.05 - p<0.001). En la coagulacion se observo una disminucion significativa en cuanto a la actividad protrombinica y del tiempo de tromboplastina parcial, (p<0.005 y 0.0001). Esto expliacria los sangrados menstruales prolongados y abundantes. Finalmente, la fibrinolisis tuvo valores superiores a 3 horas, en relacion a os valores normales (12 hrs. 30 min). De este trabajo concluimos, que los factores geneticos influyen en la Eritropoyesis, la Hemostasia, Coagulación y Fribrinolisis, en los sujetos de la altura, lo que nos permitira continuar estos estudios, referentes a la Eritrocitosis de nuestro medio.


Subject(s)
Humans , Female , Adolescent , Adult , Partial Thromboplastin Time , Blood Platelets/cytology , Blood Platelets/physiology , Thromboplastin/physiology , Hormones/biosynthesis , Hormones/metabolism , Reference Values , Hemoglobin A/physiology , Menstrual Cycle/physiology , Blood Coagulation Factors/physiology , Blood Group Antigens/physiology , Hematocrit/trends , Data Collection/trends
18.
In. Schiabel, Homero; Slaets, Annie France Frère; Costa, Luciano da Fontoura; Baffa Filho, Oswaldo; Marques, Paulo Mazzoncini de Azevedo. Anais do III Fórum Nacional de Ciência e Tecnologia em Saúde. Säo Carlos, s.n, 1996. p.339-340, ilus, tab, graf.
Monography in Portuguese | LILACS | ID: lil-236385

ABSTRACT

Este artigo descreve uma metodologia para a obtenção de um sinal ultra-sônico que contém informações sobre o processo de coagulação, de uma amostra de plasma sangüíneo padrão-nível 1. São apresentados e analisados resultados experimentais iniciais do Tempo de Tromboplastina Parcial Ativado (TTPa), de um grupo de amostras de Plasmas Normal e Deficiente em Fat.VIII:C, em função das intensidades ultra-sônicas utilizadas.


This paper describes an ultrasonic method to extract information from plasma clotting. Initial results of time coagulation measurements of normal and haemophiliac standard plasma samples are presented for different ultrasonic field intensities and discussed.


Subject(s)
Factor VII , Factor VIII , Hemophilia A/genetics , Blood Coagulation Factors/physiology , Blood Coagulation Disorders , Transducers , Whole Blood Coagulation Time
19.
Rev. méd. hered ; 6(4): 193-5, dic. 1995.
Article in Spanish | LILACS, LIPECS | ID: lil-224490

ABSTRACT

We present a patient with upper gastrointestinal bleeding and gastric varices due to mesenteric and splenic thrombosis related with a hypercoagulable state secondary to protein Cand proteins deficiency. We also did a review of the literature about deficiency of these proteins and their importance as a cause of venous thrombosis not well recognize yet.


Subject(s)
Humans , Male , Aged , Blood Coagulation Disorders/physiopathology , Blood Coagulation Factors/physiology
20.
Rev. mex. pediatr ; 61(4): 173-8, jul.-ago. 1994. tab
Article in Spanish | LILACS | ID: lil-143189

ABSTRACT

Se estudiaron 20 niños postoperados del corazón, bajo circulación extracorpórea, que habían tenido pruebas de coagulación preoperatoria normales. Al ingresar a terapia intensiva, y 24 horas después, se les hicieron las siguientes determinaciones: hemoglobina (Hb), tiempo de protrombina (TP), tiempo parcial de tromboplastina (TPT), tiempo de trombina (TT), fibrinógeno, factores V, VIII y VIII/Von Willebrand, productos líticos de fibrina (PLF), cuenta y adhesividad plaquetaria, lisis de euglobulinas, plasminógeno y antitrombina III (ATIII). La Hb, FV y VIII, fibrinógeno, plaquetas, plasminógeno ATIII y adhesividad plaquetaria; el TP, TPT y TT, inicialmente alargados, se acortaron a las 24 horas, pero sin significación estadística. Los PLF fueron negativos en las dos ocasiones. En algunos pacientes se utilizó paquete globular, plasma frasco, vitamina K y concentrados plaquetarios. La prolongación del TP, TPT, y la disminución de la Hb, el fibrinógeno, el FV y la ATIII en el primer estudio fueron secundarios a la hemodilución, las plaquetas además disminuyen por daño físico. La adhesividad plaquetaria disminuida favorece el sangrado anormal. No se observó coagulación intravascular diseminada


Subject(s)
Humans , Male , Female , Thoracic Surgery , Hemostasis/physiology , Blood Coagulation Factors/physiology
SELECTION OF CITATIONS
SEARCH DETAIL